🔎 Trials Near Me

Beranda › Kanker Prostat Resisten Kastrasi › Michigan

Uji klinis Kanker Prostat Resisten Kastrasi di Michigan

7 studi untuk Kanker Prostat Resisten Kastrasi mencari peserta di lokasi di Michigan.

Kota di Michigan

Teks studi resmi (Bahasa Inggris)

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Profound Research LLC at Cancer and Leukemia Center, Sterling Heights
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07225946

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • University of Michigan Health System, Ann Arbor
  • Henry Ford Cancer Detroit, Detroit
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 25 Sep 2026 · NCT07164443

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  • START Midwest, Grand Rapids
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 24 Sep 2026 · NCT07719361

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

  • University of Michigan ( Site 0021), Ann Arbor
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06863272

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START Midwest, Grand Rapids
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06242470

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

  • BAMF Health, Grand Rapids
Menerima pesertaFase 1/2
Usia 18 ke atas · Pria · Diperbarui 6 Mei 2026 · NCT04868604

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

  • Barbara Ann Karmanos Cancer Institute, Detroit
Menerima pesertaFase 1/2
Usia 18 ke atas · Pria · Diperbarui 13 Apr 2026 · NCT06190899

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.